ASX LIMITED — Director's Dealing 2024

Apr 2, 2024

==> picture [481 x 5] intentionally omitted <==

==> picture [32 x 50] intentionally omitted <==

3 April 2024

Australian Securities and Investments Commission ASX Market Announcements Office Mr Benjamin Cohn-Urbach ASX Limited Senior Executive Leader, Market Infrastructure 20 Bridge Street Level 5, 100 Market Street SYDNEY NSW 2000 SYDNEY NSW 2000

APPENDIX 3Y – CHANGE OF DIRECTOR’S INTEREST NOTICE – DR HEATHER SMITH

Attached is an Appendix 3Y Change of Director’s Interest Notice for Dr Heather Smith.

Release of market announcement authorised by: Johanna O’Rourke

Group General Counsel and Company Secretary

20 Bridge Street Sydney NSW 2000

PO Box H224 Investor Support 13 12 79 Australia Square NSW 1215 asx.com.au

ASX Limited ABN 98 008 624 691

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	ASX Limited
ABN	98 008 624 691

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr Heather Joy Smith

Date of last notice 11 September 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change	27 March 2024
No. of securities held prior to change	3,750 fully paid ordinary shares directly held jointly by Dr Martin Lee Parkinson and Dr HeatherJoy Smith.
Class	Fully paid ordinary shares
Number acquired	57
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$3,788.79

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change 3,807 fully paid ordinary shares directly held jointly by Dr Martin Lee Parkinson and Dr Heather Joy Smith. Nature of change Issue of securities under the dividend

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in reinvestment plan buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 318] intentionally omitted <==

----- Start of picture text -----

Detail of contract Not applicable
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change
----- End of picture text -----

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	Not applicable
If prior written clearance was provided, on what date was this provided?	Not applicable

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3